Bixink Therapeutics (빅씽크)
Seoul, South Korea
Bixink Therapeutics is an innovative South Korean Bio-company dedicated towards establishing a new treatment paradigm via converging biotechnology and information technology. Currently focused on the field of anti-cancer drugs and digital therapeutics, Bixink started commercialization of anti-cancer drug, NERLYNX®, and aims to diligently secure follow up oncology pipeline products including cancer supportive care and oncologics with novel drug delivery. Bixink also actively seeks various opportunities for collaboration such as co-development and strategic investment to drive its momentum for growth.
Company Info
- Founded
- 2016
- Website
- bixink.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Bixink Therapeutics (빅씽크)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.